On 8/5/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock suffered a major decline of -11.2%, closing at $3.90. Moreover, trading volume in this decline was exceptionally high at 258% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -28.4% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Marker Therapeutics has a very low Appreciation Score of 6 but a good Power Rating of 79, leading to the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment